Skip to content

Jason Luoma, Ph.D.

  • About
  • Research Matters Podcast
  • Workshops / Events
  • Publications
    • Books
    • Articles / Chapters
    • Measures
  • Resources
    • ACT Resources
    • RO DBT Resources
  • Contact

Workshops / Events

My workshops are listed at:

www.portlandpsychotherapytraining.com

or

www.actwithcompassion.com/events

  • About
  • Research Matters Podcast
  • Workshops / Events
  • Publications
    • Books
    • Articles / Chapters
    • Measures
  • Resources
    • ACT Resources
    • RO DBT Resources
  • Contact

Jason Luoma Follow

I am a psychologist, scientist, and entreprenuer studying shame, psychedelics, compassion, and belonging.

jasonluoma
jasonluoma Jason Luoma @jasonluoma ·
6 Dec

Applications now open for psilocybin training retreats for healthcare professionals!
Combining Acceptance and Commitment Therapy principles with psychedelic science, these week-long immersive experiences are reshaping professional development.
#psychedelicscience 🧵

Reply on Twitter 1864855624426917985 Retweet on Twitter 1864855624426917985 Like on Twitter 1864855624426917985 3 Twitter 1864855624426917985
Retweet on Twitter Jason Luoma Retweeted
myacbs Association for Contextual Behavioral Science @myacbs ·
12 Nov

#ACBSWC We are happy to announce that the call for submissions for the ACBS World Conference 2025 in New Orleans, Louisiana, USA is now open! We are now accepting submissions for symposia, papers, panels, workshops, ignite sessions, and posters. The deadline to submit is February…

Reply on Twitter 1856366436211667167 Retweet on Twitter 1856366436211667167 3 Like on Twitter 1856366436211667167 4 Twitter 1856366436211667167
Retweet on Twitter Jason Luoma Retweeted
psyched_alpha Psychedelic Alpha @psyched_alpha ·
18 Oct

Lykos Therapeutics Provides Statement on Recent FDA Meeting.

The brief, 100-word statement says a team from Lykos met with FDA re: next steps for its MDMA NDA.

'Path forward' includes additional Phase 3 and potential independent third-party review of prior Ph 3 clinical data.

Reply on Twitter 1847372026144829523 Retweet on Twitter 1847372026144829523 5 Like on Twitter 1847372026144829523 15 Twitter 1847372026144829523
Retweet on Twitter Jason Luoma Retweeted
mishateplitskiy Misha Teplitskiy @ ICSSI @mishateplitskiy ·
10 Oct

Reasons authors give for not sharing data when their paper says "data available upon request"
https://www.nature.com/articles/s41597-021-00981-0

Reply on Twitter 1844197058225262994 Retweet on Twitter 1844197058225262994 95 Like on Twitter 1844197058225262994 380 Twitter 1844197058225262994
Retweet on Twitter Jason Luoma Retweeted
renemottus René Mõttus @renemottus ·
3 Oct

Here's some advice for (new) reviewers from a now ex-editor: Please avoid creating unnecessary work for authors, editors and ultimately readers by trying to become an (unlisted) co-author with your own preferences and wishes 1/9

Reply on Twitter 1841804880291209263 Retweet on Twitter 1841804880291209263 14 Like on Twitter 1841804880291209263 46 Twitter 1841804880291209263
Load More

Like Jason Luoma on Facebook Follow Jason Luoma on Twitter

Contact Me: [email protected]

© Jason Luoma, Ph.D. 2018

© 2025 Jason Luoma, Ph.D.